{"id":"NCT04881461","sponsor":"ALK-Abell√≥ A/S","briefTitle":"A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis","officialTitle":"A Randomised, Parallel-group, Double-blind, Placebo-controlled Phase III Trial Assessing the Efficacy and Safety of 5-grass Mix SLIT-drops in Adults With Grass Pollen-induced Rhinoconjunctivitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-10","primaryCompletion":"2023-09-26","completion":"2023-09-26","firstPosted":"2021-05-11","resultsPosted":"2024-12-16","lastUpdate":"2024-12-16"},"enrollment":445,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Allergy"],"interventions":[{"type":"DRUG","name":"5-grass mix SLIT-drops","otherNames":["SLIToneULTRA"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"5-grass mix SLIT-drops","type":"EXPERIMENTAL"}],"summary":"This is a 2 year clinical study to compare 5-grass mix SLIT-drops with placebo in relieving grass pollen-induced rhinoconjunctivitis symptoms and in use of symptom-relieving medication during the second grass pollen season (peak grass pollen season, PGPS)\n\nThe study will collect health-related quality of life data in the groups treated with 5-grass mix SLIT-drops or with placebo during the first and second PGPS.\n\nThe trial medication used is already approved to treat allergic rhinitis caused by grass pollen in adults in several countries.","primaryOutcome":{"measure":"Average Daily Allergic Rhinoconjunctivitis Total Combined Score (TCS) During the 2nd Peak Grass Pollen Season (PGPS)","timeFrame":"During the 2nd PGPS (14 days)","effectByArm":[{"arm":"Placebo","deltaMin":7.1,"sd":0.51},{"arm":"5-grass Mix SLIT-drops","deltaMin":5.22,"sd":0.42}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0036"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":48,"countries":["Czechia","Estonia","France","Latvia","Lithuania","Poland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":223},"commonTop":["COVID-19","Nasopharyngitis","Oral pruritus","Headache","Upper respiratory tract infection"]}}